BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 32808838)

  • 21. Two Pandemics, One Challenge-Leveraging Molecular Test Capacity of Tuberculosis Laboratories for Rapid COVID-19 Case-Finding.
    Homolka S; Paulowski L; Andres S; Hillemann D; Jou R; Günther G; Claassens M; Kuhns M; Niemann S; Maurer FP
    Emerg Infect Dis; 2020 Nov; 26(11):2549-2554. PubMed ID: 32956612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study.
    Xu PP; Tian RH; Luo S; Zu ZY; Fan B; Wang XM; Xu K; Wang JT; Zhu J; Shi JC; Chen F; Wan B; Yan ZH; Wang RP; Chen W; Fan WH; Zhang C; Lu MJ; Sun ZY; Zhou CS; Zhang LN; Xia F; Qi L; Zhang W; Zhong J; Liu XX; Zhang QR; Lu GM; Zhang LJ
    Theranostics; 2020; 10(14):6372-6383. PubMed ID: 32483458
    [No Abstract]   [Full Text] [Related]  

  • 23. Risk Factors Associated With Mortality Among Residents With Coronavirus Disease 2019 (COVID-19) in Long-term Care Facilities in Ontario, Canada.
    Fisman DN; Bogoch I; Lapointe-Shaw L; McCready J; Tuite AR
    JAMA Netw Open; 2020 Jul; 3(7):e2015957. PubMed ID: 32697325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A technical report from the Italian SARS-CoV-2 outbreak. Postmortem sampling and autopsy investigation in cases of suspected or probable COVID-19.
    Santurro A; Scopetti M; D'Errico S; Fineschi V
    Forensic Sci Med Pathol; 2020 Sep; 16(3):471-476. PubMed ID: 32399755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of COVID-19 in patients with concurrent co-infections: A systematic review and meta-analyses.
    Sarkar S; Khanna P; Singh AK
    J Med Virol; 2021 Apr; 93(4):2385-2395. PubMed ID: 33331656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of covid-19 among patients with chronic obstructive pulmonary disease and tuberculosis.
    Muneeb Hassan M; Ameeq M; Jamal F; Tahir MH; Mendy JT
    Ann Med; 2023 Dec; 55(1):285-291. PubMed ID: 36594409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parallels in the pathogenesis of SARS-CoV-2 and
    Tapela K; Ochieng' Olwal C; Quaye O
    Future Microbiol; 2020 Dec; 15():1691-1695. PubMed ID: 33404259
    [No Abstract]   [Full Text] [Related]  

  • 28. [COVID-19, tuberculosis and induced mortality].
    Underner M; Perriot J; Peiffer G; Jaafari N
    Rev Mal Respir; 2020 Dec; 37(10):836-838. PubMed ID: 33069503
    [No Abstract]   [Full Text] [Related]  

  • 29. Experiences, challenges and looking to the future in a clinical tuberculosis cohort in the time of COVID-19 in the Philippines.
    Ferrer JP; Suzuki S; Alvarez C; Berido C; Caballero M; Caraig B; Flores PI; Juson RJ; Lustresano A; Opinion T; Saavedra M; Verde A; Faguer BN; Cox SE; Solon JA
    Trans R Soc Trop Med Hyg; 2021 Jun; 115(6):579-582. PubMed ID: 33693916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune responses in COVID-19 and tuberculosis coinfection: A scoping review.
    Flores-Lovon K; Ortiz-Saavedra B; Cueva-Chicaña LA; Aperrigue-Lira S; Montes-Madariaga ES; Soriano-Moreno DR; Bell B; Macedo R
    Front Immunol; 2022; 13():992743. PubMed ID: 36090983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maintaining essential tuberculosis services during the COVID-19 pandemic, Philippines.
    Calnan M; Moran A; Jassim AlMossawi H
    Bull World Health Organ; 2022 Feb; 100(2):127-134. PubMed ID: 35125537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 in tuberculosis patients: A report of three cases.
    He G; Wu J; Shi J; Dai J; Gamber M; Jiang X; Sun W; Cai J
    J Med Virol; 2020 Oct; 92(10):1802-1806. PubMed ID: 32343410
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention and planning as important factors in ensuring public health in the Philippines during the COVID-19 pandemic.
    De Vero MKB; Gozum IEA; Melad AM
    J Public Health (Oxf); 2021 Jun; 43(2):e358-e359. PubMed ID: 33693878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TBC and COVID: an interplay between two infections.
    Murdaca G; Paladin F; Mangini G; Tiso D; Gangemi S
    Expert Opin Drug Saf; 2023 Apr; 22(4):303-311. PubMed ID: 37079022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increase in disseminated TB during the COVID-19 pandemic.
    Barrett J; Painter H; Rajgopal A; Keane D; John L; Papineni P; Whittington A
    Int J Tuberc Lung Dis; 2021 Feb; 25(2):160-166. PubMed ID: 33656432
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of COVID-19 in patients with concurrent tuberculosis coinfections.
    Wang G; Cai L; Chen D; Teng T; Li Q; Xie L
    J Med Virol; 2021 Apr; 93(4):1937-1939. PubMed ID: 33458822
    [No Abstract]   [Full Text] [Related]  

  • 37. [HIV in the time of COVID-19 : the meeting between two pandemics].
    Nawej Tshikung O; Buvelot H; Calmy A; Cavassini M
    Rev Med Suisse; 2021 Jan; 17(720-1):95-101. PubMed ID: 33443839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects.
    Visca D; Ong CWM; Tiberi S; Centis R; D'Ambrosio L; Chen B; Mueller J; Mueller P; Duarte R; Dalcolmo M; Sotgiu G; Migliori GB; Goletti D
    Pulmonology; 2021; 27(2):151-165. PubMed ID: 33547029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tuberculosis and COVID-19 coinfection].
    Vanzetti CP; Salvo CP; Kuschner P; Brusca S; Solveyra F; Vilela A
    Medicina (B Aires); 2020; 80 Suppl 6():100-103. PubMed ID: 33481740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Care of tuberculosis patients in the times of COVID-19.
    Tale S; Meitei Soibam P
    Indian J Tuberc; 2021 Apr; 68(2):285-286. PubMed ID: 33845968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.